Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis-Reference-Cited by-同舟云学术

Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis

Published:2014-07-31 Issue:3 Volume:26 Page:235-239
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Viswanathan Hema N.,Chau Dina,Milmont Cassandra E.,Yang Wenjjing,Erondu Ngozi,Revicki Dennis A.,Klekotka Paul

Publisher

Informa UK Limited

Subject

Dermatology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference14 articles.

1. Quality of Life in Patients with Psoriasis: A Systematic Literature Review

2. Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial

3. Relationship between Clinical Response to Therapy and Health-Related Quality of Life Outcomes in Patients with Moderate to Severe Plaque Psoriasis

4. Adalimumab treatment is associated with improvement in health‐related quality of life in psoriasis: Patient‐reported outcomes from a Phase II randomized controlled trial

5. Severe Psoriasis – Oral Therapy with a New Retinoid

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis;JAMA Dermatology;2024-08-21

2. Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial;Dermatology and Therapy;2024-08-17

3. Disease severity in moderate‐to‐severe plaque psoriasis: Results from the Belgian REDISCOVER study;JEADV Clinical Practice;2024-07-02

4. Evaluating prevalence and consequence of residual disease in individuals with psoriasis receiving apremilast treatment: results from a US patient survey;Journal of Dermatological Treatment;2024-06-24

5. Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study;Clinical Rheumatology;2024-06-07